Dennis Gilbert has become CSO and vice president for research of Applied Biosystems, as well as vice president of Applera, the company said in an SEC filing today. He joined Applera in 1994 as a research scientist and was most recently ABI's vice president for advanced research and technology.
Kevin Corcoran has resigned as CEO, president, and director of Lynx Therapeutics "to pursue another business opportunity," Lynx said last week. He will be replaced by Mary Schramke, Lynx's vice president of product development, who will become acting CEO on Dec. 15. Schramke will lead the company as it proceeds with its merger with Solexa. She holds a PhD in microbiology from
Lion Bioscience made a number of additional management changes last week: Thure Etzold has been appointed as CEO, and Peter Willinger as CFO. Daniel Keesman stepped down as COO and co-CEO, and Martin Hollenhorst as CFO and co-CEO. Also, Joseph Donahue moved off the executive board but remains president of Lion's US subsidiary and responsible for global sales. In addition, J rgen Dormann, Klaus Pohle, and Richard Roy left the company's supervisory board.
Warren Meltzer has been appointed to the newly created position of vice president of legal affairs and general counsel of Orchid BioSciences, the company said yesterday. He will also serve as corporate secretary. Prior to joining Orchid, Meltzer had his own legal practice. Meltzer holds a JD from the
Thomas Watkins has become CEO of Human Genome Sciences, succeeding William Haseltine, who retired last month, HGS said on Monday. He will also join the company's board of directors. Watkins joins HGS from TAP Pharmaceutical Products, a company jointly owned by Abbott Laboratories and Takeda Pharmaceutical, where he was president. Watkins holds an MBA from the University of Chicago Graduate School of Business and a bachelor's degree from the College of William and Mary.
David Hansen will lead health data integration research efforts at
Michael Gribskov has joined the department of biological sciences at
Susan Desmond-Hellmann has joined the board of directors of Affymetrix, the company said on Monday. She is president of product development at Genentech. Desmond-Hellmann holds a bachelor and a medical degree from the
Theo Melas-Kyriazi, former CFO of Thermo Electron, has joined the board of directors of Cyberkinetics Neurotechnology Systems, the Foxborough, Mass.-based company said earlier this month. Melas-Kyriazi, who resigned from Thermo in October, holds a bachelor's degree from
Michael Pellini has become the first entrepreneur-in-residence of BioAdvance, the Philadelphia-based funding organization said last week. He used to be CEO of Genomics Collaborative, which was recently acquired by SeraCare Life Sciences. He is also a founding member of the Greater Philadelphia Bioinformatics Alliance. Pellini holds an MD from the Jefferson Medical College of Thomas Jefferson University and an MBA from
Markus Rampp and Thomas Soddemann have received this year's Billing Award for scientific computing for developing bioinformatics software, Max Planck Society said last week. The prize comes with €3,000 ($3,900). The researchers, both at MPS' Rechenzentrum Garching, developed a workflow engine that facilitates the use and linking of various bioinformatics software tools for the analysis of gene and protein sequences.